Anti-Obesity Drugs Global Strategic Business Report 2024: Market to Reach $4.8 Billion by 2030 - Saxenda Commands the AOM Market, Newer Drugs to Provide Impetus to Market Growth
May 07, 2024 10:41 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Anti-Obesity Drugs Market to...
Global Anti-Obesity Drugs Market Report 2021 Featuring Alizyme, Arena Pharmaceuticals, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Currax Pharmaceuticals
August 23, 2021 04:53 ET
|
Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Anti-Obesity Drugs Market (2021-2026) by Drug Type, Drug Class, Medication, Distribution Channel, Geography, Competitive Analysis and the Impact...
Obesity Market Spotlight Report 2020: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-Specific Revenue Forecasts
October 30, 2020 03:28 ET
|
Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Market Spotlight: Obesity" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Obesity market,...